Board Meetings for JUBLPHARMA
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| JUBLPHARMA | Jubilant Pharmova Limited | 27 Jul 2018 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 | |
| JUBLPHARMA | Jubilant Pharmova Limited | 27 Jun 2018 | Fund Raising | Proposal to consider issue of Non-Convertible Debentures | |
| JUBLPHARMA | Jubilant Pharmova Limited | 09 May 2018 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2018 and dividend | |
| JUBLPHARMA | Jubilant Pharmova Limited | 17 Jan 2018 | Results | To inter-alia consider Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended December 31, 2017. | |
| JUBLPHARMA | Jubilant Pharmova Limited | 28 Oct 2017 | Results | To inter alia consider Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended September 30, 2017. | |
| JUBLPHARMA | Jubilant Pharmova Limited | 18 Jul 2017 | Results | To inter alia consider Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2017. | |
| JUBLPHARMA | Jubilant Pharmova Limited | 17 Jul 2017 | Results | inter alia, to consider and approve the Standalone Unaudited Financial Results of the Company for the quarter ended June 30, 2017. | |
| JUBLPHARMA | Jubilant Pharmova Limited | 23 May 2017 | Results/Dividend | To inter alia consider: 1. Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2017. 2. Recommendation of Dividend for the Financial Year ended March 31, 2017. | |
| JUBLPHARMA | Jubilant Pharmova Limited | 07 Feb 2017 | Results | To inter-alia consider Unaudited Financial Results of the Company for the quarter ended December 31, 2016. | |
| JUBLPHARMA | Jubilant Pharmova Limited | 27 Oct 2016 | Results | to inter-alia consider Unaudited Financial Results of the Company for the quarter ended September 30, 2016. | |
| JUBLPHARMA | Jubilant Pharmova Limited | 27 Oct 2016 | Others | Inter-alia consider the proposal to issue Non-Convertible Debentures up to an amount of Rs.1,000 crore. | |
| JUBLPHARMA | Jubilant Pharmova Limited | 09 Aug 2016 | Results | To inter-alia consider Unaudited Financial Results of the Company for the quarter ended June 30, 2016.Further, as per the Company s Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company would remain closed for the Designated Persons of the Company from August 2, 2016 to August 11, 2016 (both days inclusive) | |
| JUBLPHARMA | Jubilant Pharmova Limited | 24 May 2016 | Results/Dividend | To inter-alia consider:1. Audited Financial Results of the Company for the year ended March 31, 2016;2. Recommendation of Dividend for the year ended March 31, 2016. | |
| JUBLPHARMA | Jubilant Pharmova Limited | 09 Feb 2016 | Results | to inter-alia consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2015. | |
| JUBLPHARMA | Jubilant Pharmova Limited | 29 Oct 2015 | Allotment of Securities | Inter-alia consider the proposal to issue securities which may include equity shares and/or instruments or securities convertible into, exchangeable with or otherwise linked to the equity shares of the Company, up to an amount of USD 200 million or Rs. 1300 crores approx. |